RSS
14 Sep 2022

Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn’s Disease Patients

Author: admintech | Filed under: Press Release

SAN DIEGO, Sept. 14, 2022 /PRNewswire/ — Prometheus Laboratories Inc. (“Prometheus”) today announced its partnership with Takeda Pharmaceutical Company Limited (“Takeda”) to nationally launch CDPATH, an innovative prognostic tool for Crohn’s disease (CD) patients. CDPATH is a…

This entry was posted on Wednesday, September 14th, 2022 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»